Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response

BACKGROUND: N6-methyladenosine (m6A) modification plays an essential role in diverse key biological processes and may take part in the development and progression of hepatocellular carcinoma (HCC). Here, we systematically analyzed the expression profiles and prognostic values of 13 widely reported m...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hongye, Ning, Gang, Wang, Yensheng, Lv, Weibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213471/
https://www.ncbi.nlm.nih.gov/pubmed/34221187
http://dx.doi.org/10.1155/2021/5576683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213471/
https://www.ncbi.nlm.nih.gov/pubmed/34221187
http://dx.doi.org/10.1155/2021/5576683

Ejemplares similares